BioSyent Named One of Canada’s Top Growing Companies 2026

MISSISSAUGA, Ontario, Sept. 25, 2026 /CourierPR/ -- BioSyent Inc., a specialty healthcare products company, has been named one of Canada’s Top Growing Companies for 2026 by The Globe and Mail’s Report on Business magazine. The company ranked 343 on the list, based on its impressive three-year revenue growth of 54% (2022-2025). This recognition is a significant milestone for BioSyent, highlighting the company’s consistent growth and financial performance.

René Goehrum, President and CEO of BioSyent, expressed pride in the recognition.

The ranking is a testament to BioSyent's commitment to innovation and patient care, as well as its ability to navigate the complexities of the healthcare industry. As of the date of the press release, the company has 11,232,335 common shares outstanding. The full 2026 ranking of Canada’s Top Growing Companies is available online at globeandmail.com and will appear in the October issue of Report on Business magazine.

BioSyent Inc. is a profitable growth-oriented company focused on acquiring or in-licensing, marketing, and distributing innovative pharmaceutical and oral health products. The company supports healthcare professionals by marketing its products through its Pharmaceutical and Oral Health businesses, both in Canada and internationally. This recognition underscores BioSyent's dedication to expanding its product offerings and contributing to the success of the healthcare sector.

The company's growth is attributed to its strategic focus on profitable expansion and the trust it has earned from patients and healthcare providers. BioSyent continues to prioritize innovation and quality, ensuring that its products meet the needs of patients and healthcare professionals. The 64 consecutive profitable quarters in Q2 2026 reflect the company's consistent financial performance and its ability to sustain growth over an extended period.